Table 1 The anti-TMV activity of I-1–I-10, II-1–II-5 and III-1–III-4.

From: Natural phytoalexin stilbene compound resveratrol and its derivatives as anti-tobacco mosaic virus and anti-phytopathogenic fungus agents

Compounds

Concentration (μg/mL)

Relative inhibition rate (%)a

Inactivation effect

Curative effect

Protection effect

I-1

500

32 ± 2

  

I-2

500

36 ± 1

  

I-3

500

34 ± 3

  

I-4

500

35 ± 3

  

I-5

500

42 ± 4

  

I-6

500

38 ± 2

  

I-7

500

37 ± 2

  

I-8

500

38 ± 3

  

I-9

500

54 ± 1

54 ± 4

55 ± 3

100

24 ± 1

15 ± 1

20 ± 1

I-10

500

51 ± 1

56 ± 2

47 ± 2

100

21 ± 1

18 ± 2

17 ± 2

II-1

500

23 ± 5

  

II-2

500

43 ± 1

44 ± 4

40 ± 2

100

24 ± 2

15 ± 1

0

II-3

500

39 ± 3

  

II-4

500

41 ± 5

43 ± 2

46 ± 2

100

26 ± 1

0

25 ± 1

II-5

500

54 ± 1

52 ± 2

51 ± 4

100

25 ± 2

28 ± 1

23 ± 1

III-1

500

30 ± 2

  

III-2

500

50 ± 1

53 ± 1

59 ± 4

100

25 ± 2

20 ± 2

28 ± 1

III-3

500

38 ± 3

  

III-4

500

57 ± 1

59 ± 3

51 ± 4

100

20 ± 2

26 ± 1

21 ± 1

Resveratrolb

500

50 ± 1

43 ± 2

45 ± 2

100

13 ± 1

15 ± 1

18 ± 1

Ribavirinb

500

38 ± 2

37 ± 1

40 ± 1

100

11 ± 2

13 ± 1

12 ± 1

  1. aAverage of three replicates. All results are expressed as the mean ± standard deviation (SD). Prominent activity data were presented in italics.
  2. bPositive control.